Prebona reported lower sales and a wider net loss in 2024 due to delayed launches and weak demand, but achieved strong progress in HealthCare and secured new funding for growth. The outlook for 2025 is positive, with expected sales increases and continued innovation.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.